EDARBI

Drug Azurity Pharmaceuticals, Inc.
Total Payments
$30,938
Transactions
1,721
Doctors
1,081
Companies
2

Payment Trends by Year

Year Amount Transactions Doctors
2024 $30,452 1,706 1,066
2022 $473.38 14 14
2021 $12.82 1 1

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $30,938 1,721 100.0%

Top Doctors Receiving Payments for EDARBI — Page 44

Doctor Specialty Location Total Records
, M.D Internal Medicine Pascagoula, MS $13.10 1
, NP Family Ocean Springs, MS $13.10 1
, MD Family Medicine Coraopolis, PA $13.08 1
Kaitlin Roslen Family Cape Girardeau, MO $12.82 1
, M.D Internal Medicine Brooklyn, NY $12.00 1
, MD Neurology Brooklyn, NY $12.00 1

About EDARBI

EDARBI is a drug associated with $30,938 in payments to 1,081 healthcare providers, recorded across 1,721 transactions in the CMS Open Payments database. The primary manufacturer is Azurity Pharmaceuticals, Inc..

Payment data is available from 2021 to 2024. In 2024, $30,452 was paid across 1,706 transactions to 1,066 doctors.

The most common payment nature for EDARBI is "Food and Beverage" ($30,938, 100.0% of total).